Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Weight Loss

Recent news which mentions Weight Loss

< Previous 1 2 3 Next >
Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Tickers AMGN LLY NVO
Tags General KeyProj Technicals
From Benzinga
Novo Nordisk Q3 Preview: Will $285 Million Weight Loss Bet Offset Bearish Charts?
Tickers ASND NVO
Tags Expert Ideas Technicals glp/1
From Benzinga
Eli Lilly Q3 Earnings On Deck: Stock Split Rumors Heat Up With Weight Loss Gains
Tickers LLY
Tags Previews Analyst Ratings Market News
From Benzinga
Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments
Tickers LLY
Tags KeyProj Market News Zepbound
From Benzinga
Lose Weight With Novo Nordisk Drugs, Gain Money With Stock
Tickers NVO
Tags Ozempic Technicals Weight Loss
From Benzinga
EXCLUSIVE: Novo Nordisk Faces Political Heat Over Weight-Loss Drug Prices Ahead Of Elections, Yet 'The Real Issue Is With The Middlemen'
Tickers HRTS NVO
Tags ETFs Expert Ideas Weight Loss
From Benzinga
Novo Nordisk To Consider Ways For Patients To Affordably Access Weight Loss Drugs Ozempic, Wegovy, Says CEO
Tickers NVO
Tags Insurance Lars Fruergaard Jorgensen Government
From Benzinga
Corbus Pharma (CRBP) Stock Drops 60% After Novo Nordisk's Cannabinoid-Based Weight Loss Drug Trial Disappoints
Tickers CRBP NEWS NVO
Tags Cannabis Market News Markets
From Benzinga
European Drug Agency Supports Novo Nordisk's Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure
Tickers NEWS NVO
Tags Briefs Biotech Weight Loss
From Benzinga
Viking Therapeutics Stock Could Soar 45% Ahead Of Key Weight Loss Drug Readout: JPMorgan
Tickers VKTX
Tags VKTX Analyst Ratings oral/2735
From Benzinga
September Volatility Returns As Labor Cools, Bets On Large Fed Rate Cut Intensify, Semiconductors Plunge: This Week In The Markets
Tickers AAPL EVS F NVDA
Tags SOXX Market News NVDA
From Benzinga
Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern
Tickers AMGN LLY NVO PFE
Tags Market News Global VKTX
From Benzinga
Hims & Hers Health Sees Major Growth Opportunity In Booming Weight Loss Market, Says Analyst
Tickers HIMS IBUY NEWS PTH
Tags PTH Price Target Briefs
From Benzinga
Novo Nordisk Vs. Eli Lilly: Beyond The Weight-Loss Drug Battle
Tickers LLY NVO
Tags Ozempic Top Stories NVO
From Benzinga
Weight-Loss Giant Novo Nordisk Tumbles To 200-Day Average Support: 'Weakness Could Be Buying Opportunity,' Analyst Says
Tickers NVO
Tags Expert Ideas Stories That Matter weight loss drugs
From Benzinga
What's Going On With HIMS Shares Today?
Tickers HIMS LLY NEWS
Tags Market News why it's moving HIMS
From Benzinga
Inflation Drop Fuels Rate Cut Speculation, Investors Shift To Sector Laggards, Russell 2000 Surges Over 3.6%: This Week In The Markets
Tickers AAPL ECON GOOGL IWM
Tags GOOGL XLRE Stories That Matter
From Benzinga
Eli Lilly's Mounjaro Outpaces Novo Nordisk's Ozempic In Weight Loss Effectiveness, Study Shows
Tickers LLY NEWS NVO
Tags Benzinga Weight Loss Mounjaro
From Benzinga
EXCLUSIVE: GLP-1 Weight-Loss Drugs Could Become A Trillion-Dollar Market, Predicts Tema ETFs CEO
Tickers ABBV ALNY AMGN HRTS
Tags Market News MRK LLY
From Benzinga
How the Workout Guru resource helps those who want to live a healthier lifestyle
Tags Health Weight Loss United States
From PRLog
Novo Nordisk To Restrict Initial Wegovy Sales In China Amid High Demand
Tickers BABA JD LLY NEWS
Tags Briefs Biotech Weight Loss
From Benzinga
Hims & Hers Health Stock Is Sliding Thursday: What's Going On?
Tickers HIMS NEWS NVO
Tags Top Stories NVO Equities
From Benzinga
Wegovy, Ozempic Maker Novo Nordisk To Invest $4.1B In US Manufacturing, Doubling Plant Size To Meet Surging Demand For Weight Loss Drugs
Tickers NEWS NVO
Tags Benzinga Weight Loss Markets
From Benzinga
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
Tickers AMGN AZN BMY GILD
Tags Media General PFE
From Benzinga
JPMorgan's $500M Venture Capital Fund Bets Big On Weight-Loss Drugs: 'They're All The Rage'
Tickers JPM LLY NEWS NVO
Tags Briefs Stories That Matter Benzinga
From Benzinga
Humans Clamor For Weight Loss Drugs, But The Next Users Could Be... Pets?
Tickers BTTR BX KKR LLY
Tags BX pets Market News
From Benzinga
ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential
Tickers LLY NEWS NVO OZEM
Tags Stories That Matter Benzinga New ETFs
From Benzinga
Chinese Generic Ozempic, Wegovy Versions Could Put Novo Nordisk At The Risk Of Stiff Competition In Key Market
Tickers LLY NEWS NVO
Tags NVO LLY Health Care
From Benzinga
Can Krispy Kreme Overcome Ozempic Fears And Become The Next Chipotle?
Tickers CMG DNUT MCD WING
Tags CMG Market News DNUT
From Benzinga
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk
Tickers LLY NVO OZEM
Tags amycretin Market News GLP/1 drugs
From Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.